Fed’s Powell opens door to potential rate cuts at Jackson Hole
Investing.com - JMP Securities raised its price target on Option Care Health (NASDAQ:OPCH) to $38.00 from $36.00 on Thursday, while maintaining a Market Outperform rating following the company’s second-quarter earnings report. The healthcare company, currently valued at $5.02 billion, has demonstrated strong momentum with a 32% year-to-date return and maintains a GREAT financial health score according to InvestingPro analysis.
Option Care Health reported revenue of $1.42 billion for the second quarter, representing 15% year-over-year growth and exceeding both JMP’s estimate of $1.33 billion and the consensus expectation of $1.35 billion.
The healthcare company demonstrated balanced growth across its business segments, with mid-teens percentage increases in both acute and chronic therapies contributing to the revenue outperformance.
Gross profit reached $269.0 million, growing 8% compared to the same period last year and surpassing JMP’s projection of $260.0 million.
Adjusted EBITDA came in at $114.0 million, a 5% year-over-year increase, which topped JMP’s estimate of $108.0 million and the consensus forecast of $110.8 million.
In other recent news, Option Care Health reported its second-quarter earnings for 2025, surpassing Wall Street expectations. The company achieved an earnings per share of $0.41, which was higher than the forecasted $0.38, representing a surprise of 7.89%. Additionally, Option Care Health’s revenue reached $1.42 billion, exceeding the anticipated $1.35 billion. These results highlight the company’s financial performance during the quarter. Despite the positive earnings report, broader market trends and investor concerns were reflected in pre-market trading. This development is part of the recent updates surrounding the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.